These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15293978)

  • 1. Novel "second-generation" approaches for the control of type 2 diabetes.
    Rotella DP
    J Med Chem; 2004 Aug; 47(17):4111-2. PubMed ID: 15293978
    [No Abstract]   [Full Text] [Related]  

  • 2. [A therapeutic option for type-2 diabetes. The incretion hormone GLP-1].
    Göke B; Hoppe B; Konrad A; Schirra J
    Pharm Unserer Zeit; 2002; 31(3):294-9. PubMed ID: 12071126
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.
    Knudsen LB
    J Med Chem; 2004 Aug; 47(17):4128-34. PubMed ID: 15293981
    [No Abstract]   [Full Text] [Related]  

  • 4. Theratechnologies expands peptide portfolio in endocrinology.
    Walczak IM
    Diabetes Technol Ther; 2002; 4(5):734. PubMed ID: 12458565
    [No Abstract]   [Full Text] [Related]  

  • 5. [New diabetes therapy in clinical trial: will need adapted insulin supply be available soon? (interview by Dr. Judith Neumaier)].
    Allolio B
    MMW Fortschr Med; 2004 Feb; 146(9):10. PubMed ID: 15352699
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel strategies for the pharmacological management of type 2 diabetes.
    Nourparvar A; Bulotta A; Di Mario U; Perfetti R
    Trends Pharmacol Sci; 2004 Feb; 25(2):86-91. PubMed ID: 15102494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
    McIntosh CH; Demuth HU; Pospisilik JA; Pederson R
    Regul Pept; 2005 Jun; 128(2):159-65. PubMed ID: 15780435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gut response. The next generation of type 2 drugs.
    Kordella T
    Diabetes Forecast; 2004 Apr; 57(4):39-42. PubMed ID: 15119299
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.
    Holst JJ; Deacon CF
    Curr Opin Pharmacol; 2004 Dec; 4(6):589-96. PubMed ID: 15525549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
    Herman GA; Stein PP; Thornberry NA; Wagner JA
    Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
    Diamant M; Bunck MC; Heine RJ
    Ned Tijdschr Geneeskd; 2004 Sep; 148(39):1912-7. PubMed ID: 15495988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 derivatives and dipeptidyl peptidase-IV inhibitors. New hope for the treatment of type-2 diabetes.
    Al-Omar MA; Al-Arifi MN
    Saudi Med J; 2005 Oct; 26(10):1511-5. PubMed ID: 16228047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
    Hooft van Huijsduijnen R; Sauer WH; Bombrun A; Swinnen D
    J Med Chem; 2004 Aug; 47(17):4142-6. PubMed ID: 15293983
    [No Abstract]   [Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Henke BR
    J Med Chem; 2004 Aug; 47(17):4118-27. PubMed ID: 15293980
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches in the treatment of type 2 diabetes.
    Zhang BB; Moller DE
    Curr Opin Chem Biol; 2000 Aug; 4(4):461-7. PubMed ID: 10959776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.
    Larsen PJ; Holst JJ
    Regul Pept; 2005 Jun; 128(2):97-107. PubMed ID: 15780429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
    Uçkaya G; Delagrange P; Chavanieu A; Grassy G; Berthault MF; Ktorza A; Cerasi E; Leibowitz G; Kaiser N
    J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.
    Deacon CF; Holst JJ
    Biochem Biophys Res Commun; 2002 May; 294(1):1-4. PubMed ID: 12054731
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.